Share
Market Research Report

DIABETES DEVICES AND DRUGS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By CategoryDiagnosis and Monitoring · Therapeutics
  • By Disease TypeType 2 Diabetes · Type 1 Diabetes
  • By GeographyNorth America · Latin America · Europe · Asia Pacific · Middle East & Africa
  • Published In31 Mar 2026
  • Report CodeCMI3857
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Category
      • Market Snapshot, By Disease Type
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Recent Product Launches
    • Epidemiology
    • Merger, Acquisition, and Collaborations
    • Regulatory Scenario
    • Key Developments
    • PEST Analysis
    • Pipeline Analysis
  4. Global Diabetes Devices and Drugs Market, By Category, 2021 – 2033, (US$ Billion)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Diagnosis and Monitoring
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
      • Segment Trends
        • Blood Glucose Monitoring Devices
        • Software Programs for Diabetes Monitoring
        • Artificial Pancreas
        • Other Testing Devices
    • Therapeutics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
      • Segment Trends
        • Insulin
        • Insulin Delivery
        • Oral Hypoglycemic Agents
        • Cell Therapies
  5. Global Diabetes Devices and Drugs Market, By Disease Type, 2021 – 2033 (US$ Billion)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Type 2 Diabetes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Billion)
    • Type 1 Diabetes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Billion)
  6. Global Diabetes Devices and Drugs Market, By Region, 2021 – 2033, (US$ Billion)

    • Overview
      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Regions, 2022–2033
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Category, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Billion)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Category, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Billion)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Category, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Billion)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Category, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Billion)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Category, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Billion)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Category, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Billion)
        • North Africa
        • Central Africa
        • South Africa
  7. Competitive Landscape

    • Company Profiles
    • Abbott Laboratories
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Bristol-Myers Squibb
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • DexCom, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Eli Lilly and Company
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Companion Medical
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • GlaxoSmithKline plc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Glenmark Pharmaceuticals
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Johnson & Johnson
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Lupin Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • F. Hoffmann-La Roche AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • DreaMed Diabetes
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Hua Medicine
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Sanofi
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
  8. Section

    • Research Methodology
    • About Us